دانشگاه تربیت دبیر شهید رجائی

  اخبار و اعلانات

 آمار

تعداد نشریات13
تعداد شماره‌ها200
تعداد مقالات2,008
تعداد مشاهده مقاله2,679,647
تعداد دریافت فایل اصل مقاله1,936,958
Akhavan-Safar, M., Teimourpour, B., Ayyoubi, M.. (1403). CinfuMax: An Influence Maximization-based Model for Detecting Cancer Driver Genes in Gene Regulatory Networks. فناوری آموزش, (), 373-386. doi: 10.22061/jecei.2024.10026.673
M. Akhavan-Safar; B. Teimourpour; M. Ayyoubi. "CinfuMax: An Influence Maximization-based Model for Detecting Cancer Driver Genes in Gene Regulatory Networks". فناوری آموزش, , , 1403, 373-386. doi: 10.22061/jecei.2024.10026.673
Akhavan-Safar, M., Teimourpour, B., Ayyoubi, M.. (1403). 'CinfuMax: An Influence Maximization-based Model for Detecting Cancer Driver Genes in Gene Regulatory Networks', فناوری آموزش, (), pp. 373-386. doi: 10.22061/jecei.2024.10026.673
Akhavan-Safar, M., Teimourpour, B., Ayyoubi, M.. CinfuMax: An Influence Maximization-based Model for Detecting Cancer Driver Genes in Gene Regulatory Networks. فناوری آموزش, 1403; (): 373-386. doi: 10.22061/jecei.2024.10026.673

CinfuMax: An Influence Maximization-based Model for Detecting Cancer Driver Genes in Gene Regulatory Networks

Journal of Electrical and Computer Engineering Innovations (JECEI)
مقالات آماده انتشار، پذیرفته شده، انتشار آنلاین از تاریخ 11 اردیبهشت 1403
نوع مقاله: Original Research Paper
شناسه دیجیتال (DOI): 10.22061/jecei.2024.10026.673
نویسندگان
M. Akhavan-Safar1؛ B. Teimourpour* 2؛ M. Ayyoubi3
1Department of Computer and Information Technology Engineering, Payame Noor University (PNU), Tehran, Iran.
2Department of Information Technology, Faculty of Industrial and Systems Engineering, Tarbiat Modares University (TMU), Tehran, Iran
3Department of Data Science, Tarbiat Modares University (TMU), Tehran, Iran.
تاریخ دریافت: 27 تیر 1402،  تاریخ بازنگری: 17 فروردین 1403،  تاریخ پذیرش: 20 فروردین 1403 
چکیده
Background and Objectives: One of the important topics in oncology treatment and prevention is the identification of genes that initiate cancer in cells. These genes are known as cancer driver genes (CDGs). Identification of the CDGs is important both for a basic understanding of cancer and to help find new therapeutic or biomarker goals. Several computational methods to find the genes responsible for cancer have been developed based on genome data. However, many of these methods find key mutations in genomic data to predict which genes are responsible for cancer. These methods depend on the mutation and genome data and often show a high rate of false positives in the results. In this study, we proposed an influence maximization-based approach, CinfuMax, which can detect the genes responsible for cancer without needing information on mutations.
Methods: In this method, the concept of influence maximization and the independent cascade model are employed. Firstly, the gene regulatory network for breast, lung and colon cancers was built using regulatory interactions and gene expression data. Next, we implemented an independent cascade diffusion algorithm on the networks to compute each gene's coverage. Finally, the genes with the highest coverage were classified as driver.
Results: The results of the proposed method were compared to 19 other computational and network-based methods based on the F-measure and the number of detected driver genes. The results demonstrated that the proposed method produces better results than other methods. Also, CinfuMax is able to detect 18, 19 and 22 individual driver genes in three breast, lung and colon cancers, respectively, which have not been identified in any of the previous methods.
Conclusion: The results show that independent cascading methods to identify driver genes perform better than linear threshold methods. Driver genes are also classified in terms of influence speed and have identified the genes with the highest diffusion rate in each type of cancer. Identification of these genes can be useful for molecular therapies and drug purposes.
کلیدواژه‌ها
Cancer Drivers؛ Influence Maximization؛ Independent Cascade Model؛ Influence Speed؛ Regulatory Networks
مراجع
[1] F.  Cheng, J. Zhao, Z. Zhao, “Advances in computational approaches for prioritizing driver mutations and significantly mutated genes in cancer genomes,” Briefings Bioinf., 17(4): 642-56, 2016.

[2] H. S. Jang, N. M. Shah, A.Y. Du, Z. Z. Dailey, E. C. Pehrsson, P. M. Godoy, D. Zhang, D. Li, X. Xing, S. Kim, D. O’Donnell “Transposable elements drive widespread expression of oncogenes in human cancers,” Nat. Genet., 51(4): 611-617, 2019.

[3] World Health Organization, Cancers, 12 September 2018.

[4] D. Tamborero, A. Gonzalez-Perez, N. Lopez-Bigas, “OncodriveCLUST: exploiting the positional clustering of somatic mutations to identify cancer genes,” Bioinf., 29(18): 2238-2244, 2013.

[5] A. Youn, R. Simon, “Identifying cancer driver genes in tumor genome sequencing studies,” Bioinf., 27(2): 175-181, 2011.

[6] F. Vandin, E. Upfal, B. J. Raphael, “De novo discovery of mutated driver pathways in cancer,” Genome Res., 22(2): 375-385, 2012.

[7] J. Reimand, O. Wagih, G. D. Bader,  “The mutational landscape of phosphorylation signaling in cancer,” Sci. Rep., 3(1): 2651, 2013.

[8] E. Porta-Pardo, A. Godzik, “e-Driver: a novel method to identify protein regions driving cancer,” Bioinf. 30(21): 3109-3014, 2014.

[9] A. Gonzalez-Perez, N. Lopez-Bigas, “Functional impact bias reveals cancer drivers,” Nucleic Acids Res., 40(21): e169, 2012.

[10] J. Zhao, S. Zhang, L. Y. Wu, X. S. Zhang, “Efficient methods for identifying mutated driver pathways in cancer,” Bioinf., 28(22): 2940-2947, 2012.

[11] Y. Han, J. Yang, X. Qian, W. C. Cheng, S. H. Liu, X. Hua, L. Zhou, Y. Yang, Q. Wu, P. Liu, Y. Lu, “DriverML: a machine learning algorithm for identifying driver genes in cancer sequencing studies,” Nucleic Acids Res., 47(8): e45, 2019.

[12] M. S. Lawrence, P. Stojanov, P. Polak, G. V. Kryukov, K. Cibulskis, A. Sivachenko, S. L. Carter, C. Stewart, C. H. Mermel, S. A. Roberts, A. Kiezun, “Mutational heterogeneity in cancer and the search for new cancer-associated genes,” Nature, 499(7457): 214-218, 2018.

[13] M. R. Aure, I. Steinfeld, L. O. Baumbusch, K. Liestøl, D. Lipson, S. Nyberg, B. Naume, K. K. Sahlberg, V. N. Kristensen, A. L. Børresen-Dale, O. C. Lingjærde, “Identifying in-trans process associated genes in breast cancer by integrated analysis of copy number and expression data,” PloS one, 8(1): e53014, 2013.

[14] E. Cerami, E. Demir, N. Schultz, B. S. Taylor, C. Sander, “Automated network analysis identifies core pathways in glioblastoma,” PloS one, 5(2): e8918, 2010.

[15] H. P. Hou, J. Ma, “DawnRank: discovering personalized driver genes in cancer,” Genome Med., 6: 1-6, 2014.

[16] G. Ciriello, E. Cerami, C. Sander, N. Schultz, “Mutual exclusivity analysis identifies oncogenic network modules,” Genome Res., 22(2): 398-406, 2012.

[17] D. Arneson, A. Bhattacharya, L. Shu, V. P. Mäkinen, X. Yang, “Mergeomics: a web server for identifying pathological pathways, networks, and key regulators via multidimensional data integration,” BMC Genomics, 17: 1-9, 2016.

[18] A. Bashashati, G. Haffari, J. Ding, G. Ha, K. Lui, J. Rosner, D. G. Huntsman, C. Caldas, S. A. Aparicio, S. P. Shah, “DriverNet: uncovering the impact of somatic driver mutations on transcriptional networks in cancer,” Genome biol., 13(12): 1-4, 2012.

[19] M. Rahimi, B. Teimourpour, S. A. Marashi, “Cancer driver gene discovery in transcriptional regulatory networks using influence maximization approach,” Comput. Biol. Med., 114: 103362, 2019.

[20] T. M. Liggett, Interacting particle systems. New York: Springer; 1985 Feb 13.

[21] J. Goldenberg, B. Libai, E. Muller, “Talk of the network: A complex systems look at the underlying process of word-of-mouth,” Mark. Lett., 12: 211-223, 2001.

[22] W. O. Kermack, A. G. McKendrick, “Contributions to the mathematical theory of epidemics--I. 1927,” Bull. Math. Biol., 53(1-2): 33-55, 1991.

[23] D. Kempe, J. Kleinberg, É. Tardos, “Influential nodes in a diffusion model for social networks,” in Proc. Automata, Languages and Programming (ICALP 2005): 1127-1138, 2005.

[24] A. Blais, B. D. Dynlacht, “Constructing transcriptional regulatory networks,” Gene. Dev., 19(13): 1499, 2005.

[25] C. A. Jackson, D. M. Castro, G. A. Saldi, R. Bonneau, D. Gresham, “Gene regulatory network reconstruction using single-cell RNA sequencing of barcoded genotypes in diverse environments,” elife, 9: e51254, 2020.

[26] J.M. Vaquerizas, S. K. Kummerfeld, S. A. Teichmann, N. M. Luscombe, “A census of human transcription factors: function, expression and evolution,” Nat. Rev. Genet., 10(4): 252-263, 2009.

[27] Z. P. Liu, C. Wu, H. Miao, H. Wu, “RegNetwork: an integrated database of transcriptional and post-transcriptional regulatory networks in human and mouse,” Database, bav095, 2015.

[28] E. Clough, T. Barrett, “The gene expression omnibus database,” Statistical Genomics: Methods and Protocols: 93-110, 2016.

[29] I. F. Chung, C. Y. Chen, S. C. Su, C. Y. Li, K. J. Wu, H. W. Wang, W. C. Cheng, “DriverDBv2: a database for human cancer driver gene research,” Nucleic Acids Res., 44(D1): D975-D979, 2016.

[30] K. Tomczak, P. Czerwińska, M. Wiznerowicz, “Review The Cancer Genome Atlas (TCGA): an immeasurable source of knowledge,” Contemp. Oncol., 19(1A): 68-77, 2015.

[31] M. R. Grever, S. A. Schepartz, B. A. Chabner, “The national cancer institute: cancer drug discovery and development program,” in Proc. InSeminars in Oncology, 19(6): 622-638, 1992.

[32] Q. X. Meng, K. N. Wang, J. H. Li, H. Zhang, Z. H. Chen, X. J. Zhou, X. C. Cao, P. Wang, Y. Yu, ZNF384–ZEB1 feedback loop regulates breast cancer metastasis,” Mol. Med., 28(1): 111, 2022.

[33] M. Jafari, Y. Guan, D. C. Wedge, N. Ansari-Pour, “Re-evaluating experimental validation in the Big Data Era: a conceptual argument,” Genome Biol., 22(1): 1-6, 2021.

[34] Y. Lu, Y. Wang, N. Sheng, H. Wang, Y. Fu, Y. Tian, “RDDriver: A novel method based on multi-layer heterogeneous transcriptional regulation network for identifying pancreatic cancer biomarker,” in Proc. 2022 IEEE International Conference on Bioinformatics and Biomedicine (BIBM): 497-502, 2022.

[35] F. Dietlein, D. Weghorn, A. Taylor-Weiner, A. Richters, B. Reardon, D. Liu, E. S. Lander, E. M. Van Allen, S. R. Sunyaev, “Identification of cancer driver genes based on nucleotide context,” Nat. Genet.,  52(2): 208-218, 2020.

[36] R. Gillman, M. A. Field, U. Schmitz, R. Karamatic, L. Hebbard, “Identifying cancer driver genes in individual tumours,” Comput. Struct. Biotechnol. J., 21: 5028-5038, 2023.

آمار
تعداد مشاهده مقاله: 124


سامانه مدیریت نشریات علمی. قدرت گرفته از سیناوب